Skip to main content
. Author manuscript; available in PMC: 2021 Dec 21.
Published in final edited form as: Anticancer Res. 2021 Dec;41(12):5919–5933. doi: 10.21873/anticanres.15411

Figure 4.

Figure 4.

Normalized protein expression of CCL2/MCP-1 and IL-6 in MDA-MB-231 (A and C) and MDA-MB-468 (B and D) triple negative breast cancer cells. Data represent normalized dot spot intensities from the cytokine arrays based on the positive controls found in each of the membranes’ corners using RAYBIO®ANALYSIS software (RayBiotech). Data are expressed as % of control (mean±S.E.M. n=3), representing treatment with TNF-α (40 ng/ml) and co-treatment with DATS (75 μM)+TNF-α (40 ng/ml). Student’s t-test evaluated the statistically significant differences between TNF-α vs. co-treatment, with **p<0.01. NS: Non-significant.